| BioAnaLab moves to larger premises |
|
 |
BioAnaLab receives GMP accreditation from MHRA |
 |
BioAnaLab appoints David Oxlade as Chair of the Board of Directors |
 |
BioAnaLab achieves full membership of the UK Good Laboratory Practice Compliance Programme |
 |
BioAnaLab raises new investment to expand its analytical services |
|
BioAnaLab announces an eight-fold increase in turnover during the second year of operation |
 |
BioAnaLab appoints Geoff Hale as CEO |
 |
BioAnaLab wins Best New Start-up Laboratory at the Laboratory News Industry Awards
|
 |
BioAnaLab
moves into new premises at the Magdalen Centre, Oxford
Science Park |
 |
ILEX(tm)
Oncology, Inc. (Nasdaq: ILXO) has agreed in principle
to exclusively sublicense CAMPATH(tm)-related diagnostic
testing rights for Europe, the Middle East and Israel
to UK-based BioAnaLab Ltd. |
 |
BioAnaLab
Ltd. is launched |
 |

|